Saik Andrew
Arvinas, Inc. · Chief Financial Officer
Saik Andrew is listed in filings as Chief Financial Officer at Arvinas, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity. Recent filings connect the profile to Arvinas, Inc. (ARVN) and Milestone Pharmaceuticals Inc. (MIST). The current snapshot covers public activity from Jun 26, 2024 to May 13, 2026. Reported amounts are shown as $110.7K to $61.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $61k5.1k shares | SellFeb 13, 2026 | $11.89 | $8.85 | |
| $43k5.7k shares | SellJun 24, 2025 | $7.61 | $8.85 |